International survey on NAT testing of blood donations: Expanding implementation and yield from 1999 to 2009

Vox Sanguinis

Volumn 102, Issue 1, 2012, Pages 82-90

  Kurt Roth, Willi ^a   Schuller, Annette ^a   Busch, Michael P ^b   Reesink, Henk W ^c   Panzer, Simon ^d  

^a GFE Blut mbH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

BLOOD BANK; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; CLINICAL PROTOCOL; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE TRANSMISSION; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION; MEDICAL EXPERT; MEDICAL TECHNOLOGY; NOTE; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; VIRUS DETECTION; VIRUS REPLICATION;

BLOOD DONORS; BLOOD TRANSFUSION; DISEASE TRANSMISSION, INFECTIOUS; DNA, VIRAL; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 84655164775     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01506.x     Document Type: Note

References (7)

1. McCullough J, Bianco C, Busch M, et al.: Interagency Genome Amplification Testing Task Force: preliminary report. Transfusion 1998; 38(10):903-904. PubMed PMID: 9767738.
2. Schottstedt V, Tuma W, Bünger G, et al.: PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service. Biologicals 1998; 26(2):101-104.
3. Cardoso MS, Koerner K, Hinz W, et al.: Experiences in HCV-NAT screening prior to releasing cellular components by the German Red Cross Blood Transfusion Service of Baden-Württemberg. Biologicals 1999; 27(4):281-284.
4. Roth WK, Weber M, Seifried E.: Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 1999; 353(9150):359-363.
5. Busch MP, Kleinman SH, Jackson B, et al.: Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000; 40(2):143-159. PubMed PMID: 10685998.
6. Engelfriet CP, Reesink HW.: Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology. Vox Sang 2002; 82:87-111.
7. Coste J, Reesink HW, Engelfriet CP, et al.: Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang 2005; 88(4):289-303.